These compounds mimic the natural GLP-1 hormone, which plays an essential role in controlling appetite, regulating blood sugar, and slowing digestion
Pushing through intense exercise when energy is already low is likely to make fatigue worse rather than better
Nisciors joy, however, was short-lived
Conclusion The evidence supports a nuanced conclusion regarding GLP-1 agonists for obesity in non-diabetic patients: they represent a significant therapeutic advance with game-changing potential currently limited by practical implementation challenges
New clients are welcomed with a complimentary consultation to map out a plan that fits their goals, their body, and the life they actually live.
Preclinical and mechanistic studies have shown promise